DOI: 10.36347/sjams.2019.v07i03.083

Pages: 1276-1280

Introduction: Now a days there are many treatment are available for treating Acute ST-elevation myocardial infarction (STEMI) which is a major causative factor heart attack but even though still thrombolytic therapy or streptokinase use in many hospital. Objective: In this study our main goal is to evaluate the complications of thrombolytic therapy (streptokinase) in patients of acute ST elevation myocardial infarction (STEMI). Method: This cross-sectional study was done at BSMRAU medical college and hospital from April 2013 to April 2015 where 217 patients were studied. During the study patients who treated with the streptokinase were administered as soon as possible after the first symptoms of STEMI and all the data were checked also edited and analyzed after collection. Result: In the study majority of the patients were male (n = 179, 83%) and medical history of patients who received streptokinase where most of the patients had history of hypotension and & smoking. Also the most common ADRs for streptokinase were chest pain, hypotension, coughing, and ecchymosis. Conclusion: We can conclude that patients undergo adverse health complications by taking streptokinase. Further qualitative and quantitative analysis is needed for better outcome.